Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 1,687.52 | 1,574.21 | 1,566.43 | 1,237.36 | 1,091.23 |
| Operating profit | 347.04 | 425.02 | 465.87 | 424.27 | 244.13 |
| Interest | 1.34 | 7.88 | 1.24 | 2.55 | 3.77 |
| Gross profit | 459.49 | 473.46 | 548.04 | 521.06 | 345.63 |
| EPS (Rs) | 24.70 | 38.39 | 44.89 | 38.87 | 22.44 |
Half yearly
results in details
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 113.79 | 56.32 | 83.41 | 99.34 | 105.27 |
| Stock adjustment | 30.19 | -67.65 | 11.05 | -66.91 | -28.14 |
| Raw material | 400.46 | 415.62 | 357.42 | 340.92 | 309.29 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 337.82 | 294.01 | 291.86 | 241.98 | 224.28 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 572.01 | 507.21 | 440.23 | 297.10 | 341.67 |
| Provisions made | - | - | - | - | - |
| Depreciation | 62.55 | 60.80 | 60.16 | 54.06 | 47.39 |
| Taxation | 79.39 | 83.11 | 97.57 | 126.09 | 98.56 |
| Net profit / loss | 317.55 | 329.55 | 390.31 | 340.91 | 196.83 |
| Extra ordinary item | - | - | - | - | -2.85 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.71 | 17.17 | 17.39 | 17.54 | 17.54 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 20.57 | 27.00 | 29.74 | 34.29 | 22.37 |
| GPM (%) | 25.51 | 29.04 | 33.22 | 38.98 | 28.89 |
| NPM (%) | 17.63 | 20.21 | 23.66 | 25.50 | 16.45 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis